African Horse Sickness
Basic Information 
Definition
• African horse sickness (AHS) is caused by a double-stranded, nonenveloped RNA virus that affects members of the family Equidae and is transmitted by midges (Culicoides spp.). Horses and mules are the most severely affected.
• There are nine distinct serotypes, with types 5 and 9 most commonly occurring outside of the endemic sub-Saharan Africa. Four major forms of the disease exist: peracute or pulmonary (95% mortality rate), subacute or cardiac (50% mortality rate), mixed (70% mortality rate), and horse sickness fever (recovery). The onset of disease in the severe forms is characterized by a high fever followed by respiratory failure with a frothy to serosanguineous nasal discharge or nondependent edema of the head and neck with petechiations of the conjunctiva. There is no effective treatment.
• A polyvalent vaccine exists that provides protection for all serotypes. Quarantine, constant monitoring, and vector control are necessary. This disease has not been documented in North America and is a World Organisation for Animal Health (OIE)–reportable disease.
Epidemiology
Species, Age, Sex
• Horses are most susceptible to infection, with a mortality rate of 70% to 95% depending on the form of the disease.
• Mules are slightly less susceptible, with a mortality rate of 50% to 70%.
• Donkeys and zebras develop subclinical disease.
• There does not appear to be an age predilection. Foals born to immune mares may receive passive immunity that disappears at age 4 to 6 months.
Geography and Seasonality
• AHS is considered to be enzoonotic in eastern and central Africa, with yearly incursions of the disease into southern Africa. Documented and confirmed epidemics have occurred in North Africa, the Middle East, Turkey, Afghanistan, Pakistan, India, Spain, and Portugal. To date, the virus has never been documented in North America.
• Maintenance of AHS in the environment.

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

